[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Loo et al., 2004 - Google Patents

Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein

Loo et al., 2004

View HTML @Full View
Document ID
15774758515647695809
Author
Loo T
Bartlett M
Clarke D
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

P-glycoprotein (P-gp; ABCB1) transports a wide variety of structurally diverse compounds out of the cell. The protein has two homologous halves joined by a linker region. Each half consists of a transmembrane (TM) domain with six TM segments and a nucleotide-binding …
Continue reading at www.jbc.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay

Similar Documents

Publication Publication Date Title
Loo et al. Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein
Loo et al. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein: direct evidence for the substrate-induced fit mechanism for drug binding
Loo et al. The “LSGGQ” motif in each nucleotide-binding domain of human P-glycoprotein is adjacent to the opposing walker A sequence
Loo et al. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein
Loo et al. Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers
Loo et al. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane
Loo et al. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12
Loo et al. Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains
Loo et al. Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate
Rodriguez et al. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains
Snyder et al. Electrophysiological and biochemical evidence that DEG/ENaC cation channels are composed of nine subunits
Loo et al. P-glycoprotein: ASSOCIATIONS BETWEEN DOMAINS AND BETWEEN DOMAINS AND MOLECULAR CHAPERONES (∗)
Berman et al. The GTPase-activating protein RGS4 stabilizes the transition state for nucleotide hydrolysis
Nakajima et al. A relationship between protein kinase C phosphorylation and calmodulin binding to the metabotropic glutamate receptor subtype 7
Potter et al. A Direct Regulatory Role for Troponin T and a Dual Role for Troponin C in the Ca2+ Regulation of Muscle Contraction (∗)
Yamaguchi et al. An Eps homology (EH) domain protein that binds to the Ral-GTPase target, RalBP1
Lee et al. Dynamic regulation of cystic fibrosis transmembrane conductance regulator by competitive interactions of molecular adaptors
Loo et al. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites
Wojnar et al. Molecular cloning of a novel lipocalin-1 interacting human cell membrane receptor using phage display
Ghosh et al. Receptor-and nucleotide exchange-independent mechanisms for promoting G protein subunit dissociation
Campbell et al. Molecular modeling correctly predicts the functional importance of Phe594 in transmembrane helix 11 of the multidrug resistance protein, MRP1 (ABCC1)
Hoff et al. Contributions of the LPPVK motif of the iron-sulfur template protein IscU to interactions with the Hsc66-Hsc20 chaperone system
Loo et al. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site
Huang et al. Dissecting cAMP binding domain A in the RIα subunit of cAMP-dependent protein kinase: distinct subsites for recognition of cAMP and the catalytic subunit
Onions et al. Basic helix-loop-helix protein sequences determining differential inhibition by calmodulin and S-100 proteins